Showing 1 - 7 results of 7 for search 'Alberto J. Montero', query time: 0.05s
Refine Results
-
1
Estimating the overall survival benefit of adjuvant chemo‐endocrine therapy in women over age 50 with pT1‐2N0 early stage breast cancer and 21‐gene recurrence score ≥26: A National... by Nickolas Stabellini, Lifen Cao, Christopher W. Towe, Amanda L. Amin, Alberto J. Montero
Published 2023-10-01
Article -
2
Adjuvant chemotherapy is associated with an overall survival benefit regardless of age in ER+/HER2- breast cancer pts with 1-3 positive nodes and oncotype DX recurrence score 20 to... by Nickolas Stabellini, Nickolas Stabellini, Nickolas Stabellini, Lifen Cao, Christopher W. Towe, Christopher W. Towe, Christopher W. Towe, Xun Luo, Xun Luo, Xun Luo, Amanda L. Amin, Amanda L. Amin, Amanda L. Amin, Alberto J. Montero, Alberto J. Montero
Published 2023-04-01
Article -
3
-
4
-
5
Radiomic predicts early response to CDK4/6 inhibitors in hormone receptor positive metastatic breast cancer by Mohammadhadi Khorrami, Vidya Sakar Viswanathan, Priyanka Reddy, Nathaniel Braman, Siddharth Kunte, Amit Gupta, Jame Abraham, Alberto J. Montero, Anant Madabhushi
Published 2023-08-01
Article -
6
Survival in elderly patients with breast cancer with and without autoimmune disease by Demitrios Dedousis, Annie L. Zhang, Anastasia N. Vassiliou, Shufen Cao, Deepthi Yammani, Ravi K. Kyasaram, John P. Shanahan, Melissa C. Keinath, Melinda L. Hsu, Pingfu Fu, Afshin Dowlati, Alberto J. Montero
Published 2023-06-01
Article -
7
Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (“METRIC”): a randomized multicenter study by Linda T. Vahdat, Peter Schmid, Andres Forero-Torres, Kimberly Blackwell, Melinda L. Telli, Michelle Melisko, Volker Möbus, Javier Cortes, Alberto J. Montero, Cynthia Ma, Rita Nanda, Gail S. Wright, Yi He, Thomas Hawthorne, Rebecca G. Bagley, Abdel-Baset Halim, Christopher D. Turner, Denise A. Yardley
Published 2021-05-01
Article